Advancing nanomedicine into patient therapy

Clinical Trials/
Tumor Types

Advancement

Phase I
Feasibility study


Phase II
Efficacy study
Pancreatic carcinoma
Glioblastoma multiforme
EU Regulatory Approval
Prostata carcinoma